載入...
A Single Intravitreal Injection of Ranibizumab Provides No Neuroprotection in a Nonhuman Primate Model of Moderate-to-Severe Nonarteritic Anterior Ischemic Optic Neuropathy
PURPOSE: Ranibizumab, a vascular endothelial growth factor-antagonist, is said to be neuroprotective when injected intravitreally in patients with nonarteritic anterior ischemic optic neuropathy (NAION). We evaluated the efficacy of a single intravitreal (IVT) injection of ranibizumab in a nonhuman...
Na minha lista:
| 發表在: | Invest Ophthalmol Vis Sci |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The Association for Research in Vision and Ophthalmology
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4669855/ https://ncbi.nlm.nih.gov/pubmed/26624498 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.15-18015 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|